Avenzo Therapeutics

BiotechnologySeries BSan Diego, USavenzotx.com

Latest round

Series B

Last raised

Aug 2025

Total raised

$402M

Investors

13

About Avenzo Therapeutics

Founded in 2022 and based in California, US, Avenzo Therapeutics, Inc. operates as a clinical-stage biotechnology company that develops and offers an oncology platform intended to develop novel treatments for underserved cancers. In September 2025, Avenzo Therapeutics, Inc.   The firm develops and provides oncology therapies to address cancers with high unmet medical needs. The firm’s lead program, AVZO-021, targets cyclin-dependent kinase 2 (CDK2), to treat various cancers, including HR+ breast cancer, ovarian cancer, and small-cell lung cancer. The platform selectively inhibits CDK2 to overcome resistance to existing therapies and improve treatment outcomes.

Who invested in Avenzo Therapeutics

13 investors across 3 rounds

See all investors in Avenzo Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Aug 22, 2025

    Amount

    $47M

    Investors

    Locked

  2. Series A

    Nov 19, 2024

    Amount

    $163M

    Investors

    Locked

  3. Series A

    Mar 26, 2024

    Amount

    $192M

    Investors

    Locked

Questions about Avenzo Therapeutics

Who invested in Avenzo Therapeutics?

Avenzo Therapeutics has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Avenzo Therapeutics raised?

Avenzo Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Avenzo Therapeutics last raise money?

Avenzo Therapeutics's most recent round on record is a Series B, in Aug 2025.

What does Avenzo Therapeutics do?

Founded in 2022 and based in California, US, Avenzo Therapeutics, Inc.

Where is Avenzo Therapeutics headquartered?

Avenzo Therapeutics is headquartered in San Diego, US.

Which VCs invest in companies like Avenzo Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Avenzo Therapeutics's stage. Their profiles are linked below.

Raising like Avenzo Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.